-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Zura Bio, Raises Price Target to $20

Benzinga·08/12/2026 12:28:33
Listen to the news
Guggenheim analyst Yatin Suneja maintains Zura Bio (NASDAQ:ZURA) with a Buy and raises the price target from $15 to $20.